12-49033482-TTGCTGCTGCTGC-TTGCTGCTGCTGCTGC
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS2
The NM_003482.4(KMT2D):c.11222_11223insGCA(p.Gln3744dup) variant causes a inframe insertion change. The variant allele was found at a frequency of 0.0014 in 1,611,336 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 5 hom. )
Consequence
KMT2D
NM_003482.4 inframe_insertion
NM_003482.4 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.57
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP3
?
Nonframeshift variant in repetitive region in NM_003482.4
BP6
?
Variant 12-49033482-T-TTGC is Benign according to our data. Variant chr12-49033482-T-TTGC is described in ClinVar as [Likely_benign]. Clinvar id is 94150.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
?
High AC in GnomAd at 261 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KMT2D | NM_003482.4 | c.11222_11223insGCA | p.Gln3744dup | inframe_insertion | 40/55 | ENST00000301067.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KMT2D | ENST00000301067.12 | c.11222_11223insGCA | p.Gln3744dup | inframe_insertion | 40/55 | 5 | NM_003482.4 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.00172 AC: 261AN: 151764Hom.: 0 Cov.: 33
GnomAD3 genomes
?
AF:
AC:
261
AN:
151764
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00164 AC: 384AN: 233912Hom.: 2 AF XY: 0.00163 AC XY: 207AN XY: 127272
GnomAD3 exomes
AF:
AC:
384
AN:
233912
Hom.:
AF XY:
AC XY:
207
AN XY:
127272
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00136 AC: 1991AN: 1459450Hom.: 5 Cov.: 47 AF XY: 0.00144 AC XY: 1043AN XY: 726016
GnomAD4 exome
AF:
AC:
1991
AN:
1459450
Hom.:
Cov.:
47
AF XY:
AC XY:
1043
AN XY:
726016
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00172 AC: 261AN: 151886Hom.: 0 Cov.: 33 AF XY: 0.00170 AC XY: 126AN XY: 74262
GnomAD4 genome
?
AF:
AC:
261
AN:
151886
Hom.:
Cov.:
33
AF XY:
AC XY:
126
AN XY:
74262
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:6
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 17, 2020 | This variant is associated with the following publications: (PMID: 30107592, 27302555, 23757202) - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 24, 2018 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 28, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | KMT2D: BS1, BS2 - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 08, 2019 | - - |
Benign, no assertion criteria provided | clinical testing | Eurofins Ntd Llc (ga) | Dec 19, 2012 | - - |
Kabuki syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 18, 2024 | - - |
Kabuki syndrome 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Human Genetics, Inc, Center for Human Genetics, Inc | Nov 01, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at